Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Vopr Onkol ; 61(4): 667-70, 2015.
Article in Russian | MEDLINE | ID: mdl-26571842

ABSTRACT

Drug therapy for symptomatic multiple myeloma is comparable for both sexes in its effectiveness and safety. A 3-year event-free survival is comparable in men and women; overall survival in men is lower than in women.


Subject(s)
Antineoplastic Agents/therapeutic use , Multiple Myeloma/drug therapy , Adult , Aged , Disease-Free Survival , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multiple Myeloma/complications , Multiple Myeloma/mortality , Sex Factors , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL